FeesSafety
Pluang+

Starknet votes to research quantum-resistant independent blockchain with 93.5% support

Protocol Fundamentals
22 Oct 2026
Crypto Briefing
View Source
Bullish
Starknet votes to research quantum-resistant independent blockchain with 93.5% support

Starknet's community voted with 93.5% in favor to explore becoming an independent layer 1 blockchain designed to resist quantum computing threats. Over 3,200 wallets participated, marking the highest turnout in a Starknet poll. This vote initiates a research phase led by StarkWare and the Starknet Foundation, aiming to produce a draft white paper by November and potentially launch a quantum-safe blockchain by 2027. The move seeks to reduce Starknet's reliance on Ethereum for security, as Ethereum's quantum-safe target is 2029, leaving Starknet exposed to delays in Ethereum's upgrades. Current user experience and token roles remain unchanged during this research phase.

Starknet's vote on exploring a quantum-resistant blockchain comes with this market context from Pluang. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 22, 2026 19:31 WIB: out of 50 major cryptocurrencies, 6 rose and 43 fell. Notable movers include EOS at Rp12.649 with an 8.13% increase and SAND at Rp972 down 6.80%.

More News

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown opens new Huntsville Test & Qualification Center to boost aerospace and defense testing.

Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...

Market News
Bullish
13 minutes ago
60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

60% of CCOs say communications functions lag behind their leadership roles, needing better systems and resources.

A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...

Others
Neutral
13 minutes ago
Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

Over 200 companies advance 240+ Alzheimer's drugs, marking a new phase in treatment development

More than 200 companies are actively developing over 240 Alzheimer's disease therapies, with around 20 drugs in late-stage trials and many others in earlier phases. Key players include Eli Lilly, Biogen, Johnson & Johnson, and Eisai, focusing on inno...

Market News
Bullish
13 minutes ago
Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences starts key Phase 3 trial for acne drug denifanstat in the U.S.

Sagimet Biosciences has initiated a crucial Phase 3 clinical trial in the U.S. for denifanstat, an oral treatment targeting moderate to severe acne. The trial, named AURORA, aims to enroll around 800 patients, including adolescents, to support regula...

Market News
Bullish
1 hour ago
Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia beats Q3 earnings and revenue estimates with strong AI and cloud sales growth.

Nokia reported third-quarter 2026 earnings per share of $0.10, surpassing the $0.08 estimate, and revenue of $5.78 billion, exceeding the $5.72 billion forecast. The company's AI and cloud sales surged 123%, driven by high demand for its IP Networks ...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App